<DOC>
	<DOCNO>NCT01468740</DOCNO>
	<brief_summary>Standard therapy HIV-related Hodgkin lymphoma ( HIV-HL ) define . This trial initiate investigate risk adapt treatment strategy patient ( pt ) HIV-HL establish HIV-negative patient HL . Treatment schedule : - Early stage favorable Hodgkin Lymphoma ( HL ) : 2 cycle doxorubicin , bleomycin , vinblastine , dacarbazine ( ABVD ) plus 30 Gy involve field ( IF ) radiation - Early stage unfavorable HL : 4 cycle bleomycin , etoposide , doxorubicin , cyclophosphamide , vincristine , procarbazine , prednisone ( BEACOPP ) -baseline 4 cycle ABVD plus 30 Gy IF radiation - Advanced HL : 8 cycle BEACOPP-baseline . BEACOPP replace ABVD pt far advance HIV-infection . After completion chemotherapy sit initial bulky disease ( least 5 cm diameter ) residual tumor large 2.5 cm diameter receive 30 Gy irradiation . - Primary outcome measure : tolerability , treatment-related mortality - Secondary outcome measure : complete remission rate , progression-free survival ( PFS ) , overall survival ( OS ) .</brief_summary>
	<brief_title>Prospective Study HIV-related Hodgkin Lymphoma</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Hodgkin Disease</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<mesh_term>Etoposide phosphate</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Vinblastine</mesh_term>
	<mesh_term>Bleomycin</mesh_term>
	<mesh_term>Procarbazine</mesh_term>
	<mesh_term>Vincristine</mesh_term>
	<criteria>age 18 75 year proven infection HIV 1 ( Elisa Western Blot ) histologyproven newly diagnose Hodgkin lymphoma write , informed consent . severe cardiac , hepatic pulmonary insufficiency severe renal insufficiency ( creatinine &gt; 2,0 mg/dl ) cause lymphoma bone marrow failure , cause lymphoma HAART ( neutrophils &lt; 1000/µl , platelet &lt; 70.000/µl ) uncontrolled infection uncontrolled drug addiction psychiatric disease pregnancy lactation period prior chemotherapy Hodgkin lymphoma life expectancy &lt; 6 week HIVrelated wastingsyndrome active secondary malignancy cervix carcinoma situ , basalioma Kaposi ` sarcoma except</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2011</verification_date>
</DOC>